BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mondelli MU, Varchetta S, Oliviero B. Natural killer cells in viral hepatitis: facts and controversies. Eur J Clin Invest. 2010;40:851-863. [PMID: 20597961 DOI: 10.1111/j.1365-2362.2010.02332.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Han Q, Li N, Zhu Q, Li Z, Zhang G, Chen J, Lv Y, Wang Y, Liu Z, Hao C. Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection. Clin Exp Med 2014;14:35-43. [DOI: 10.1007/s10238-012-0214-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology. 2012;56:1567-1574. [PMID: 22378061 DOI: 10.1002/hep.25674] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
3 Spaan M, van Oord G, Kreefft K, Hou J, Hansen BE, Janssen HL, de Knegt RJ, Boonstra A. Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment. J Infect Dis. 2016;213:216-223. [PMID: 26223768 DOI: 10.1093/infdis/jiv391] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 17.3] [Reference Citation Analysis]
4 Fugier E, Marche H, Thélu MA, Macek Jílková Z, Van Campenhout N, Dufeu-Duchesne T, Leroy V, Zarski JP, Sturm N, Marche PN, Jouvin-Marche E. Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C. PLoS One 2014;9:e95614. [PMID: 24759660 DOI: 10.1371/journal.pone.0095614] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
5 Hotho DM, Kreefft K, Groothuismink ZM, Janssen HL, de Knegt RJ, Boonstra A. Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use. Antiviral Res 2013;97:347-55. [PMID: 23291200 DOI: 10.1016/j.antiviral.2012.12.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
6 Wang XX, Pan XB, Han JC, Cong X, Jin Q, Kong XS, Wei L, Feng B. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication. Hepatobiliary Pancreat Dis Int 2018;17:233-40. [PMID: 29625837 DOI: 10.1016/j.hbpd.2018.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Spaan M, Janssen HL, Boonstra A. Immunology of hepatitis C virus infections. Best Pract Res Clin Gastroenterol. 2012;26:391-400. [PMID: 23199499 DOI: 10.1016/j.bpg.2012.09.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
8 Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon? World J Hepatol 2018;10:267-76. [PMID: 29527262 DOI: 10.4254/wjh.v10.i2.267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
9 Elemam NM, Mekky RY, El-Ekiaby NM, El Sobky SA, El Din MA, Esmat G, Abdelaziz AI. Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models. Hum Immunol 2015;76:687-94. [PMID: 26429314 DOI: 10.1016/j.humimm.2015.09.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
10 Tjwa ETTL, Zoutendijk R, van Oord GW, Biesta PJ, Verheij J, Janssen HLA, Woltman AM, Boonstra A. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B. Liver Int 2014;34:396-404. [DOI: 10.1111/liv.12272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
11 Li N, Puga Yung GL, Pradier A, Toso C, Giostra E, Morard I, Spahr L, Seebach JD. NK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry. Front Immunol. 2013;4:61. [PMID: 23482713 DOI: 10.3389/fimmu.2013.00061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
12 Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012;8:e1002594. [PMID: 22438812 DOI: 10.1371/journal.ppat.1002594] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 14.3] [Reference Citation Analysis]
13 Li X, Zhou L, Gu L, Gu Y, Chen L, Lian Y, Huang Y. Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment. J Transl Med 2017;15:220. [PMID: 29089040 DOI: 10.1186/s12967-017-1318-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tjwa ET, Zoutendijk R, van Oord GW, Boeijen LL, Reijnders JG, van Campenhout MJ, de Knegt RJ, Janssen HL, Woltman AM, Boonstra A. Similar frequencies, phenotype and activation status of intrahepatic NK cells in chronic HBV patients after long-term treatment with tenofovir disoproxil fumarate (TDF). Antiviral Research 2016;132:70-5. [DOI: 10.1016/j.antiviral.2016.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
15 Fakharzadeh S, Kalanaky S, Hafizi M, Goya MM, Masoumi Z, Namaki S, Shakeri N, Abbasi M, Mahdavi M, Nazaran MH. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Vaccine 2013;31:2591-7. [PMID: 23583463 DOI: 10.1016/j.vaccine.2013.03.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
16 Heeg M, Thimme R. Natural killer cells and hepatitis C: Natural killer p46 expression linked to antiviral and antifibrotic activity. Hepatology 2012;56:1197-200. [DOI: 10.1002/hep.25858] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
17 Yang J, Wang H, Wang M, Liu B, Xu H, Xu F, Zhao D, Hu B, Zhao N, Wang J, Liu D, Tang L, He F. Involvement of LSECtin in the hepatic natural killer cell response. Biochem Biophys Res Commun 2016;476:49-55. [PMID: 27184407 DOI: 10.1016/j.bbrc.2016.05.072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Zhang QF, Shao JY, Yin WW, Xia Y, Chen L, Wang X, Hu HD, Hu P, Ren H, Zhang DZ. Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0160171. [PMID: 27513564 DOI: 10.1371/journal.pone.0160171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Khorramdelazad H, Hassanshahi G, Nasiri Ahmadabadi B, Kazemi Arababadi M. High Serum Levels of TGF-β in Iranians With Chronic HBV Infection. Hepat Mon 2012;12:e7581. [PMID: 23346151 DOI: 10.5812/hepatmon.7581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
20 Michel ML, Deng Q, Mancini-Bourgine M. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J Hepatol. 2011;54:1286-1296. [PMID: 21238516 DOI: 10.1016/j.jhep.2010.12.031] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 9.5] [Reference Citation Analysis]
21 Wijaya RS, Read SA, Schibeci S, Eslam M, Azardaryany MK, El-Khobar K, van der Poorten D, Lin R, Yuen L, Lam V, George J, Douglas MW, Ahlenstiel G. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J Hepatol 2019;71:252-64. [PMID: 30905683 DOI: 10.1016/j.jhep.2019.03.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
22 Spengler U, Nischalke HD, Nattermann J, Strassburg CP. Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C. World J Gastroenterol 2013;19:7852-66. [PMID: 24307779 DOI: 10.3748/wjg.v19.i44.7852] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hartling HJ, Ballegaard VC, Nielsen NS, Gaardbo JC, Nielsen SD. Immune regulation in chronic hepatitis C virus infection. Scand J Gastroenterol 2016;51:1387-97. [PMID: 27436030 DOI: 10.3109/00365521.2016.1170875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
24 Yoon JC, Yang CM, Song Y, Lee JM. Natural killer cells in hepatitis C: Current progress. World J Gastroenterol 2016;22:1449-60. [PMID: 26819513 DOI: 10.3748/wjg.v22.i4.1449] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
25 Lv J, Jin Q, Sun H, Chi X, Hu X, Yan H, Pan Y, Xiao W, Tian Z, Hou J. Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients. Mediators Inflamm. 2012;2012:804043. [PMID: 23304062 DOI: 10.1155/2012/804043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
26 de Groen RA, Boltjes A, Hou J, Liu BS, McPhee F, Friborg J, Janssen HL, Boonstra A. IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells. Eur J Immunol 2015;45:250-9. [PMID: 25316442 DOI: 10.1002/eji.201444903] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
27 Xue M, Fan F, Ding L, Liu J, Su S, Yin P, Cao M, Zhao W, Hu HM, Wang L. An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation. J Transl Med 2014;12:361. [PMID: 25526800 DOI: 10.1186/s12967-014-0361-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
28 de Groen RA, Hou J, van Oord GW, Groothuismink ZM, van der Heide M, de Knegt RJ, Boonstra A. NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection. Antiviral Research 2017;140:18-24. [DOI: 10.1016/j.antiviral.2017.01.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
29 Lunemann S, Malone DF, Hengst J, Port K, Grabowski J, Deterding K, Markova A, Bremer B, Schlaphoff V, Cornberg M. Compromised function of natural killer cells in acute and chronic viral hepatitis. J Infect Dis. 2014;209:1362-1373. [PMID: 24154737 DOI: 10.1093/infdis/jit561] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
30 Wang XX, Luo BF, Jiang HJ, Cong X, Jin Q, Ma DL, Wei L, Feng B. Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir. World J Gastroenterol. 2018;24:4554-4564. [PMID: 30386105 DOI: 10.3748/wjg.v24.i40.4554] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
31 Heim MH, Thimme R. Innate and adaptive immune responses in HCV infections. J Hepatol. 2014;61:S14-S25. [PMID: 25443342 DOI: 10.1016/j.jhep.2014.06.035] [Cited by in Crossref: 170] [Cited by in F6Publishing: 143] [Article Influence: 24.3] [Reference Citation Analysis]
32 Elemam NM, Hannawi S, Maghazachi AA. Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules. Toxins (Basel) 2017;9:E398. [PMID: 29232860 DOI: 10.3390/toxins9120398] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
33 Holder KA, Russell RS, Grant MD. Natural killer cell function and dysfunction in hepatitis C virus infection. Biomed Res Int 2014;2014:903764. [PMID: 25057504 DOI: 10.1155/2014/903764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
34 Li W, Jiang Y, Wang X, Jin J, Qi Y, Chi X, Zhang H, Feng X, Niu J. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation. PLoS One. 2015;10:e0135874. [PMID: 26291078 DOI: 10.1371/journal.pone.0135874] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
35 Ghosh A, Romani S, Kottilil S, Poonia B. Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal. Int J Mol Sci. 2020;21. [PMID: 33050486 DOI: 10.3390/ijms21207473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Liu J, Liu S, Xia M, Xu S, Wang C, Bao Y, Jiang M, Wu Y, Xu T, Cao X. Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation. Proc Natl Acad Sci U S A 2013;110:7814-9. [PMID: 23610400 DOI: 10.1073/pnas.1220466110] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
37 Cho H. Phenotypic characteristics of natural killer cells in acute hepatitis. J Microbiol. 2013;51:247-251. [PMID: 23625228 DOI: 10.1007/s12275-013-2522-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
38 Refaat B, Ashshi AM, El-Shemi AG, Azhar E. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy. Mediators Inflamm 2015;2015:287640. [PMID: 25969625 DOI: 10.1155/2015/287640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
39 Holder KA, Stapleton SN, Gallant ME, Russell RS, Grant MD. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. J Immunol. 2013;191:3308-3318. [PMID: 23960237 DOI: 10.4049/jimmunol.1300164] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
40 Schuch A, Zecher BF, Müller PA, Correia MP, Daul F, Rennert C, Tauber C, Schlitt K, Boettler T, Neumann-Haefelin C, Hengel H, Pircher H, Cerwenka A, Thimme R, Hofmann M. NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection. J Hepatol 2019;70:351-60. [PMID: 30342116 DOI: 10.1016/j.jhep.2018.10.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
41 Knolle PA, Thimme R. Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology. 2014;146:1193-1207. [PMID: 24412289 DOI: 10.1053/j.gastro.2013.12.036] [Cited by in Crossref: 129] [Cited by in F6Publishing: 120] [Article Influence: 18.4] [Reference Citation Analysis]
42 Mania A, Kaczmarek M, Kemnitz P, Figlerowicz M, Sikora J, Sluzewski W, Zeromski J. Expression of Natural Killer Cell Inhibitory Receptors is Associated with Significant Liver Injury in Chronic Hepatitis C in Children. Ann Hepatol 2017;16:521-9. [PMID: 28611271 DOI: 10.5604/01.3001.0010.0281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Thimme R. NKp46+ expression on NK cells as a biomarker for liver pathology and IFN-responiveness in HCV infection. Gut 2014;63:382-4. [DOI: 10.1136/gutjnl-2013-305087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Mania A, Kaczmarek M, Kemnitz P, Mazur-Melewska K, Figlerowicz M, Sikora J, Służewski W, Żeromski J. Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C. Med Microbiol Immunol 2018;207:55-63. [PMID: 29119253 DOI: 10.1007/s00430-017-0526-x] [Reference Citation Analysis]
45 de Groen RA, Groothuismink ZMA, van Oord G, Kootstra NA, Janssen HLA, Prins M, Schinkel J, Boonstra A. NK cells in self-limited HCV infection exhibit a more extensively differentiated, but not memory-like, repertoire. J Viral Hepat 2017;24:917-26. [PMID: 28414896 DOI: 10.1111/jvh.12716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Li Y, Wang JJ, Gao S, Liu Q, Bai J, Zhao XQ, Hao YH, Ding HH, Zhu F, Yang DL, Zhao XP. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B. PLoS One. 2014;9:e86927. [PMID: 24520324 DOI: 10.1371/journal.pone.0086927] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
47 Werner JM, Heller T, Gordon AM, Sheets A, Sherker AH, Kessler E, Bean KS, Stevens M, Schmitt J, Rehermann B. Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection. Hepatology. 2013;58:1621-1631. [PMID: 23463364 DOI: 10.1002/hep.26353] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
48 Zhao J, Li Y, Jin L, Zhang S, Fan R, Sun Y, Zhou C, Shang Q, Li W, Zhang Z, Wang FS. Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients. PLoS One 2012;7:e49135. [PMID: 23133672 DOI: 10.1371/journal.pone.0049135] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
49 Serti E, Chepa-Lotrea X, Kim YJ, Keane M, Fryzek N, Liang TJ, Ghany M, Rehermann B. Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function. Gastroenterology. 2015;149:190-200.e2. [PMID: 25754160 DOI: 10.1053/j.gastro.2015.03.004] [Cited by in Crossref: 170] [Cited by in F6Publishing: 156] [Article Influence: 28.3] [Reference Citation Analysis]
50 Golden-Mason L, Rosen HR. Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunol Rev. 2013;255:68-81. [PMID: 23947348 DOI: 10.1111/imr.12090] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 7.7] [Reference Citation Analysis]
51 Martinet J, Dufeu-Duchesne T, Bruder Costa J, Larrat S, Marlu A, Leroy V, Plumas J, Aspord C. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection. Gastroenterology. 2012;143:1586-1596.e8. [PMID: 22960656 DOI: 10.1053/j.gastro.2012.08.046] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
52 Bruder Costa J, Dufeu-Duchesne T, Leroy V, Bertucci I, Bouvier-Alias M, Pouget N, Brevot-Lutton O, Bourliere M, Zoulim F, Plumas J, Aspord C; ANRS HB06 PEGAN study group. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion. PLoS One 2016;11:e0158297. [PMID: 27348813 DOI: 10.1371/journal.pone.0158297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
53 Shoukry NH, Pelletier S, Chang KM. A view to natural killer cells in hepatitis C. Gastroenterology 2011;141:1144-8. [PMID: 21875586 DOI: 10.1053/j.gastro.2011.08.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
54 Mondelli MU. NKG2D and its ligands: key to immunotherapy of liver cancer? J Hepatol 2012;56:308-10. [PMID: 21798219 DOI: 10.1016/j.jhep.2011.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
55 Debes JD, de Knegt RJ, Boonstra A. The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals. Transplantation. 2017;101:910-915. [PMID: 28045877 DOI: 10.1097/tp.0000000000001623] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
56 Ge J, Huang Z, Liu H, Chen J, Xie Z, Chen Z, Peng J, Sun J, Hou J, Zhang X. Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B. Front Immunol 2017;8:1173. [PMID: 29018442 DOI: 10.3389/fimmu.2017.01173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
57 Yang Y, Han Q, Zhang C, Xiao M, Zhang J. Hepatitis B virus antigens impair NK cell function. Int Immunopharmacol. 2016;38:291-297. [PMID: 27341035 DOI: 10.1016/j.intimp.2016.06.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
58 Zhou Y, Zhang Y, Moorman JP, Yao ZQ, Jia ZS. Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis. Immunology 2014;143:319-30. [PMID: 24965611 DOI: 10.1111/imm.12349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
59 Jouvin-Marche E, Macek Jílková Z, Thelu MA, Marche H, Fugier E, Van Campenhout N, Hoang XS, Marlu A, Sturm N, Callanan M, Leroy V, Zarski JP, Marche PN. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels. J Infect Dis 2014;209:1907-15. [PMID: 24415789 DOI: 10.1093/infdis/jiu016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
60 Ow MM, Hegazy D, Warshow UM, Cramp ME. Enhanced natural killer cell activity is found in exposed uninfected recipients of hepatitis C-contaminated blood. J Viral Hepat 2018;25:245-53. [PMID: 29063663 DOI: 10.1111/jvh.12810] [Reference Citation Analysis]
61 Yang Y, Han Q, Hou Z, Zhang C, Tian Z, Zhang J. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction. Cell Mol Immunol. 2017;14:465-475. [PMID: 27238466 DOI: 10.1038/cmi.2016.24] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 16.4] [Reference Citation Analysis]
62 Wang JM, Cheng YQ, Shi L, Ying RS, Wu XY, Li GY, Moorman JP, Yao ZQ. KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection. J Virol. 2013;87:11626-11636. [PMID: 23966413 DOI: 10.1128/jvi.01515-13] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]